196 related articles for article (PubMed ID: 31088544)
1. Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer.
Shin YJ; Kim Y; Wen X; Cho NY; Lee S; Kim WH; Kang GH
Clin Epigenetics; 2019 May; 11(1):77. PubMed ID: 31088544
[TBL] [Abstract][Full Text] [Related]
2. Methylation status of long interspersed element-1 in advanced gastric cancer and its prognostic implication.
Song YS; Kim Y; Cho NY; Yang HK; Kim WH; Kang GH
Gastric Cancer; 2016 Jan; 19(1):98-106. PubMed ID: 25609453
[TBL] [Abstract][Full Text] [Related]
3. Combination of L1 methylation and tumor-infiltrating lymphocytes as prognostic marker in advanced gastric cancer.
Kim Y; Rhee YY; Wen X; Cho NY; Bae JM; Kim WH; Kang GH
Gastric Cancer; 2020 May; 23(3):464-472. PubMed ID: 31691036
[TBL] [Abstract][Full Text] [Related]
4. Combinatory low methylation statuses of SAT-α and L1 are associated with shortened survival time in patients with advanced gastric cancer.
Kim Y; Wen X; Jeong S; Cho NY; Kim WH; Kang GH
Gastric Cancer; 2019 Jan; 22(1):37-47. PubMed ID: 29926315
[TBL] [Abstract][Full Text] [Related]
5. TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep).
Cheng LL; Itahana Y; Lei ZD; Chia NY; Wu Y; Yu Y; Zhang SL; Thike AA; Pandey A; Rozen S; Voorhoeve PM; Yu Q; Tan PH; Bay BH; Itahana K; Tan P
Clin Cancer Res; 2012 Aug; 18(15):4201-12. PubMed ID: 22675170
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtyping of gastric cancer combining genetic and epigenetic anomalies provides distinct clinicopathological features and prognostic impacts.
Tahara T; Tahara S; Horiguchi N; Okubo M; Terada T; Yamada H; Yoshida D; Omori T; Osaki H; Maeda K; Kamano T; Funasaka K; Nagasaka M; Nakagawa Y; Shibata T; Ohmiya N
Hum Mutat; 2019 Mar; 40(3):347-354. PubMed ID: 30575210
[TBL] [Abstract][Full Text] [Related]
7. Exclusive Association of p53 Mutation with Super-High Methylation of Tumor Suppressor Genes in the p53 Pathway in a Unique Gastric Cancer Phenotype.
Waraya M; Yamashita K; Ema A; Katada N; Kikuchi S; Watanabe M
PLoS One; 2015; 10(10):e0139902. PubMed ID: 26447864
[TBL] [Abstract][Full Text] [Related]
8. Survival in males with glioma and gastric adenocarcinoma correlates with mutant p53 residual transcriptional activity.
Fischer NW; Prodeus A; Gariépy J
JCI Insight; 2018 Aug; 3(15):. PubMed ID: 30089713
[TBL] [Abstract][Full Text] [Related]
9. Immune signatures correlate with L1 retrotransposition in gastrointestinal cancers.
Jung H; Choi JK; Lee EA
Genome Res; 2018 Aug; 28(8):1136-1146. PubMed ID: 29970450
[TBL] [Abstract][Full Text] [Related]
10. ALU and LINE-1 hypomethylations in multistep gastric carcinogenesis and their prognostic implications.
Bae JM; Shin SH; Kwon HJ; Park SY; Kook MC; Kim YW; Cho NY; Kim N; Kim TY; Kim D; Kang GH
Int J Cancer; 2012 Sep; 131(6):1323-31. PubMed ID: 22120154
[TBL] [Abstract][Full Text] [Related]
11. IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression.
Thiem A; Hesbacher S; Kneitz H; di Primio T; Heppt MV; Hermanns HM; Goebeler M; Meierjohann S; Houben R; Schrama D
J Exp Clin Cancer Res; 2019 Sep; 38(1):397. PubMed ID: 31506076
[TBL] [Abstract][Full Text] [Related]
12. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
Ding SL; Yang ZW; Wang J; Zhang XL; Chen XM; Lu FM
World J Gastroenterol; 2015 May; 21(20):6317-28. PubMed ID: 26034368
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of angiogenesis-related genes in human gastric cancers with and those without high-frequency microsatellite instability.
Miyamoto N; Yamamoto H; Taniguchi H; Miyamoto C; Oki M; Adachi Y; Imai K; Shinomura Y
Cancer Lett; 2007 Aug; 254(1):42-53. PubMed ID: 17374440
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of patients with microsatellite-unstable colorectal carcinomas depend on L1 methylation level.
Rhee YY; Kim MJ; Bae JM; Koh JM; Cho NY; Juhnn YS; Kim D; Kang GH
Ann Surg Oncol; 2012 Oct; 19(11):3441-8. PubMed ID: 22618722
[TBL] [Abstract][Full Text] [Related]
15. Coexisting YAP expression and TP53 missense mutations delineates a molecular scenario unexpectedly associated with better survival outcomes in advanced gastric cancer.
Pallocca M; Goeman F; De Nicola F; Melucci E; Sperati F; Terrenato I; Pizzuti L; Casini B; Gallo E; Amoreo CA; Vici P; Di Lauro L; Buglioni S; Diodoro MG; Pescarmona E; Mazzotta M; Barba M; Fanciulli M; De Maria R; Ciliberto G; Maugeri-Saccà M
J Transl Med; 2018 Sep; 16(1):247. PubMed ID: 30180862
[TBL] [Abstract][Full Text] [Related]
16. Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.
Blackburn J; Roden DL; Ng R; Wu J; Bosman A; Epstein RJ
Mol Carcinog; 2016 Dec; 55(12):1940-1951. PubMed ID: 26676339
[TBL] [Abstract][Full Text] [Related]
17. P53 deregulation in Epstein-Barr virus-associated gastric cancer.
Ribeiro J; Malta M; Galaghar A; Silva F; Afonso LP; Medeiros R; Sousa H
Cancer Lett; 2017 Sep; 404():37-43. PubMed ID: 28729047
[TBL] [Abstract][Full Text] [Related]
18. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status.
Szeliga M; Bogacińska-Karaś M; Kuźmicz K; Rola R; Albrecht J
Mol Carcinog; 2016 Sep; 55(9):1309-16. PubMed ID: 26258493
[TBL] [Abstract][Full Text] [Related]
20. PKNOX2 suppresses gastric cancer through the transcriptional activation of IGFBP5 and p53.
Zhang L; Li W; Cao L; Xu J; Qian Y; Chen H; Zhang Y; Kang W; Gou H; Wong CC; Yu J
Oncogene; 2019 Jun; 38(23):4590-4604. PubMed ID: 30745575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]